(Total Views: 472)
Posted On: 08/18/2019 8:12:40 PM
Post# of 154854
All we can do is provide facts.
Yes, CYDY has a financing issue, but leronlimab is much closer to approval than at any other time in the company’s history. There are multiple, near term solutions to the financing issue and like I said before, there are zero issues with Leronlimab itself when discussing the HIV indication.
I’m not claiming that CYDY will make everyone billionaires, but there is an upside to CYDY that can make investors many multiples of their investment if they consider making one in the near future.
Yes, CYDY has a financing issue, but leronlimab is much closer to approval than at any other time in the company’s history. There are multiple, near term solutions to the financing issue and like I said before, there are zero issues with Leronlimab itself when discussing the HIV indication.
I’m not claiming that CYDY will make everyone billionaires, but there is an upside to CYDY that can make investors many multiples of their investment if they consider making one in the near future.
(1)
(0)
